Conditions: Nocturia
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 750
Healthy volunteers: no

Brief summary:
The purpose of this study is to investigate the efficacy and safety of SER120 nasal spray formulations in patients with nocturia for a total duration of 14 weeks.

Detailed description:

Arms:
arm 1: SER120 (750 ng/day) arm 2: SER120 (1000 ng/day) arm 3: SER120 (1500 ng/day) arm 4: Placebo

Interventions: intervention 1: SER120 (750 ng/day) intervention 2: SER120 (1000 ng/day) intervention 3: SER120 (1500 ng/day) intervention 4: Placebo
Intervention descriptions: intervention 1: None intervention 2: SER120 (1000 ng/day) intervention 3: None intervention 4: None

Protocol document: